Cwm, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cwm, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$144.95 - $152.29 $5,653 - $5,939	39 Added 30.47%	167 $25,000
Q2 2022 Jul 28, 2022	BUY	$83.14 - $145.99 $997 - $1,751	12 Added 10.34%	128 $19,000
Q1 2022 Apr 21, 2022	BUY	$110.08 - $142.92 $11,888 - $15,435	108 Added 1350.0%	116 $14,000
Q4 2021 Jan 31, 2022	BUY	$99.73 - $148.48 $797 - $1,187	8 New	8 $1,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.